drug companies

Buttigieg Eyes 35% Corporate Tax Rate to Fund Health Plan

Buttigieg Eyes 35% Corporate Tax Rate to Fund Health Plan

Pete Buttigieg would pay for his $1.5 trillion health-care plan by rolling back President Donald Trump’s corporate tax cut to return the rate to 35% and allowing Medicare to negotiate drug prices,
Bill Gates on the limitations of corporate purpose

Bill Gates on the limitations of corporate purpose

CEOs focusing on societal outcomes "is not the magic bullet," says the Microsoft co-founder.
Drug Company That Makes OxyContin Files For Bankruptcy to Stop Lawsuits Over Opioid Crisis

Drug Company That Makes OxyContin Files For Bankruptcy to Stop Lawsuits Over Opioid Crisis

Purdue Pharma, the drug company that makes the controversial pain medication OxyContin, filed for bankruptcy protection late Sunday night. The bankruptcy filing will temporarily halt thousands of
Purdue Pharma offers billions to settle opioids lawsuits. Some states say it’s not enough

Purdue Pharma offers billions to settle opioids lawsuits. Some states say it’s not enough

Just how much should Purdue Pharma pay for its role in the national opioid epidemic?
Former Drug Company Execs, Pharmacists Arrested for Allegedly Flooding Small Towns With Opioids

Former Drug Company Execs, Pharmacists Arrested for Allegedly Flooding Small Towns With Opioids

Federal officials have indicted two former executives at the pharmaceutical wholesaler Miami-Luken for allegedly distributing millions of opioid pills illegally in rural Appalachia. Two pharmacists
Drug Company to Pay Just $15.4 Million Over Doctor Bribery Scandal Involving Medicine That Brings in $1 Billion a Year

Drug Company to Pay Just $15.4 Million Over Doctor Bribery Scandal Involving Medicine That Brings in $1 Billion a Year

Mallinckrodt Pharmaceuticals announced today that the company expects to pay $15.4 million in a settlement with the U.S. Justice Department after allegations that Questcor Pharmaceuticals, which
GOP Reps Suck Up To Big Pharma, Warn CEOs Not To Cooperate With Investigation

GOP Reps Suck Up To Big Pharma, Warn CEOs Not To Cooperate With Investigation

A very disturbing report getting lost in all the chaos from the purge going on at DHS broke late Monday and it has to do with some pretty blatant and egregious obstruction being committed by the
Johnson & Johnson and Bayer Settle Xarelto Lawsuits for $775 Million

Johnson & Johnson and Bayer Settle Xarelto Lawsuits for $775 Million

The drug companies agreed to settle more than 25,000 lawsuits in the U.S. and admit no liability.
Big Pharma Gives Big Money to the Senators Who Will Question Drug Company CEOs Today

Big Pharma Gives Big Money to the Senators Who Will Question Drug Company CEOs Today

The CEOs of America’s largest drug companies will testify on Capitol Hill today. But will U.S. senators really hold their feet to the fire after taking so much money from those same drug

Warning: If You Work In One of These 2 Industries, You're Most Likely to be Targeted By Hackers

New research reveals not only which industries are most vulnerable, but which job titles are most targeted.
Pharma CEO jacks drug price 400%, citing “moral requirement to make money”

Pharma CEO jacks drug price 400%, citing “moral requirement to make money”

He raised price of essential antibiotic from $475 to $2,392, then defended Shkreli.
Chinese Parents Panic Over Infant Vaccine Safety

Chinese Parents Panic Over Infant Vaccine Safety

China’s vaccine scandal is sparking protests and panic among parents, with the revelation two drugmakers sold poor-quality vaccines for infants reviving anxiety over the country’s ability to ensure
Pharmaceutical Companies Seek Stability in Trump Drug Cost Fight

Pharmaceutical Companies Seek Stability in Trump Drug Cost Fight

Several major pharmaceutical companies lowered their spending on lobbyists in the second quarter of 2018, a time of uncertainty as President Donald Trump’s administration continued its campaign to
Trump's Drug Plan Picks Up Momentum as Merck Lowers Some Prices

Trump's Drug Plan Picks Up Momentum as Merck Lowers Some Prices

The Trump administration moved swiftly in the past 24 hours to implement pieces of its plan to bring down drug prices, preparing several significant steps as one of the biggest U.S. drugmakers said it
Ex-Drug CEO Seeking Senate Seat Attacked by Old Industry Foe

Ex-Drug CEO Seeking Senate Seat Attacked by Old Industry Foe

A patient-advocacy group opposed to high drug prices says it will spend $1.5 million on ads attacking New Jersey GOP Senate candidate Bob Hugin, the former chief executive of drugmaker Celgene Corp.
Trump Attacks Pfizer Over Drug Cost in Latest Dig at Pharma

Trump Attacks Pfizer Over Drug Cost in Latest Dig at Pharma

President Donald Trump said Pfizer Inc. should be “ashamed” for raising the prices of its pharmaceutical products, briefly rattling shares of the U.S. drug giant on Monday.
Trump Says Drug Companies to Unveil Price Cuts in Two Weeks

Trump Says Drug Companies to Unveil Price Cuts in Two Weeks

Major pharmaceutical companies will announce “voluntary, massive” cuts in drug prices in two weeks, President Donald Trump said Wednesday, without providing details.
Top Lawyer at Novartis Quits After Drug Company's $1.2 Million Payment to the President's Fixer is Exposed

Top Lawyer at Novartis Quits After Drug Company's $1.2 Million Payment to the President's Fixer is Exposed

The top lawyer at pharmaceutical company Novartis has announced that he’s leaving the company today. The departure of General Counsel Felix Ehrat comes in the wake of news that Novartis had given $1.2
Trump's Drug Price Plan: What Can Happen Now and What Takes Time

Trump's Drug Price Plan: What Can Happen Now and What Takes Time

President Donald Trump’s plan to tackle high drug prices relies on policies that can be implemented fairly soon as well as many the administration wants to take time to explore, or needs help from
Drug Industry Dodges Its Worst Fears in Trump’s Plan to Lower Prices

Drug Industry Dodges Its Worst Fears in Trump’s Plan to Lower Prices

President Donald Trump’s plan to lower U.S. drug prices avoids some of the harshest steps that the pharmaceutical industry and the network of companies that distribute its products feared.